The potential role of neutrophil trogocytosis and G-CSF in the loss of HER2 expression

Z Strizova^{1

2}, J Vachtenheim Jr^{3

4}, J Bartunkova^{3

5}

Affiliations

¹ First Faculty of Medicine and Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Czech Republic. zuzana.strizova@fnmotol.cz.
² Department of Immunology, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Czech Republic. zuzana.strizova@fnmotol.cz.
³ First Faculty of Medicine and Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Czech Republic.
⁴ Third Department of Surgery, First Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Czech Republic.
⁵ Department of Immunology, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Czech Republic.

Comment

Z Strizova et al. Breast Cancer Res Treat. 2019 Nov.

. 2019 Nov;178(1):247-248.

doi: 10.1007/s10549-019-05386-7. Epub 2019 Aug 3.

Z Strizova^{1

2}, J Vachtenheim Jr^{3

4}, J Bartunkova^{3

5}

¹ First Faculty of Medicine and Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Czech Republic. zuzana.strizova@fnmotol.cz.
² Department of Immunology, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Czech Republic. zuzana.strizova@fnmotol.cz.
³ First Faculty of Medicine and Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Czech Republic.
⁴ Third Department of Surgery, First Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Czech Republic.
⁵ Department of Immunology, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Czech Republic.

No abstract available

Comment on

Loss of HER2 after HER2-targeted treatment.
Ignatov T, Gorbunow F, Eggemann H, Ortmann O, Ignatov A. Ignatov T, et al. Breast Cancer Res Treat. 2019 Jun;175(2):401-408. doi: 10.1007/s10549-019-05173-4. Epub 2019 Feb 26. Breast Cancer Res Treat. 2019. PMID: 30806922 Clinical Trial.